Racial and ethnic disparities in interval colorectal cancer incidence a population-based cohort study

Annals of Internal Medicine

Volumn 166, Issue 12, 2017, Pages 857-866

  Fedewa, Stacey A ^a   Flanders, W Dana ^b   Ward, Kevin C ^b   Lin, Chun Chieh ^a   Jemal, Ahmedin ^a   Sauer, Ann Goding ^a   Doubeni, Chyke A ^c   Goodman, Michael ^b  

^a AMERICAN CANCER SOCIETY   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; ASCENDING COLON; CANCER INCIDENCE; CANCER RISK; COLONOSCOPY; COLORECTAL CANCER; COLORECTAL POLYP; DESCENDING COLON; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RACE DIFFERENCE; AFRICAN AMERICAN; CAUCASIAN; COLONIC POLYPS; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; EPIDEMIOLOGY; ETHNOLOGY; HEALTH CARE DISPARITY; INCIDENCE; MEDICARE; RISK FACTOR; STANDARDS; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AFRICAN AMERICANS; AGED; COLONIC POLYPS; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HEALTHCARE DISPARITIES; HUMANS; INCIDENCE; MALE; MEDICARE; RISK FACTORS; UNITED STATES;

EID: 85021128051     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M16-1154     Document Type: Article

References (67)

1. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67:7-30. [PMID: 28055103] doi:10.3322/caac.21387
2. U. S. Preventive Services Task Force. Screening for colorectal cancer: U. S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149:627-37. [PMID: 18838716]
3. Doubeni CA, Weinmann S, Adams K, Kamineni A, Buist DS, Ash AS, et al. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested casecontrol study. Ann Intern Med. 2013;158:312-20. [PMID: 23460054] doi:10.7326/0003-4819-158-5-201303050-00003
4. Nishihara R, Wu K, Lochhead P, Morikawa T, Liao X, Qian ZR, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 2013;369:1095-105. [PMID: 24047059] doi: 10.1056/NEJMoa1301969
5. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:1603-7. [PMID: 11096167]
6. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occultblood screening for colorectal cancer. Lancet. 1996;348:1472-7. [PMID: 8942775]
7. Kronborg O, Fenger C, Olsen J, Jrgensen OD, Sndergaard O. Randomised study of screening for colorectal cancer with faecaloccultblood test. Lancet. 1996;348:1467-71. [PMID: 8942774]
8. Adler J, Robertson DJ. Interval Colorectal Cancer After Colonoscopy: Exploring Explanations and Solutions. Am J Gastroenterol. 2015;110:1657-64; quiz 1665. [PMID: 26553207] doi:10.1038/ajg.2015.365
9. Singh S, Singh PP, Murad MH, Singh H, Samadder NJ. Prevalence, risk factors, and outcomes of interval colorectal cancers: a systematic review and meta-analysis. Am J Gastroenterol. 2014;109:1375-89. [PMID: 24957158] doi:10.1038/ajg.2014.171
10. Corley DA, Jensen CD, Marks AR, Zhao WK, Lee JK, Doubeni CA, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014;370:1298-306. [PMID: 24693890] doi:10.1056/NEJMoa1309086
11. Cooper GS, Xu F, Barnholtz Sloan JS, Schluchter MD, Koroukian SM. Prevalence and predictors of interval colorectal cancers in medicare beneficiaries. Cancer. 2012;118:3044-52. [PMID: 21989586] doi: 10.1002/cncr.26602
12. Singh H, Turner D, Xue L, Targownik LE, Bernstein CN. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA. 2006;295:2366-73. [PMID: 16720822]
13. Samadder NJ, Curtin K, Tuohy TM, Pappas L, Boucher K, Provenzale D, et al. Characteristics of missed or interval colorectal cancer and patient survival: a population-based study. Gastroenterology. 2014;146:950-60. [PMID: 24417818] doi:10.1053/j.gastro.2014.01.013
14. DeSantis CE, Siegel RL, Sauer AG, Miller KD, Fedewa SA, Alcaraz KI, et al. Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities. CA Cancer J Clin. 2016;66:290-308. [PMID: 26910411] doi:10.3322/caac.21340
15. Lansdorp-Vogelaar I, Kuntz KM, Knudsen AB, van Ballegooijen M, Zauber AG, Jemal A. Contribution of screening and survival differences to racial disparities in colorectal cancer rates. Cancer Epidemiol Biomarkers Prev. 2012;21:728-36. [PMID: 22514249] doi:10.1158/1055-9965. EPI-12-0023
16. Irby K, Anderson WF, Henson DE, Devesa SS. Emerging and widening colorectal carcinoma disparities between Blacks and Whites in the United States (1975-2002). Cancer Epidemiol Biomarkers Prev. 2006;15:792-7. [PMID: 16614125]
17. Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Bresalier R, Lamerato LE, et al. Race and colorectal cancer disparities: healthcare utilization vs different cancer susceptibilities. J Natl Cancer Inst. 2010;102:538-46. [PMID: 20357245] doi:10.1093/jnci/djq068
18. Doubeni CA, Major JM, Laiyemo AO, Schootman M, Zauber AG, Hollenbeck AR, et al. Contribution of behavioral risk factors and obesity to socioeconomic differences in colorectal cancer incidence. J Natl Cancer Inst. 2012;104:1353-62. [PMID: 22952311]
19. Rauscher GH, Allgood KL, Whitman S, Conant E. Disparities in screening mammography services by race/ethnicity and health insurance. J Womens Health (Larchmt). 2012;21:154-60. [PMID: 21942866] doi: 10.1089/jwh.2010.2415
20. Rauscher GH, Conant EF, Khan JA, Berbaum ML. Mammogram image quality as a potential contributor to disparities in breast cancer stage at diagnosis: an observational study. BMC Cancer. 2013;13:208. [PMID: 23621946] doi:10.1186/1471-2407-13-208
21. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002;40:IV-3-18. [PMID: 12187163]
22. Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR; United States Multi-Society Task Force on Colorectal Cancer. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012;143:844-57. [PMID: 22763141] doi:10.1053/j.gastro.2012.06.001
23. Rex DK, Schoenfeld PS, Cohen J, Pike IM, Adler DG, Fennerty MB, et al. Quality indicators for colonoscopy. Am J Gastroenterol. 2015;110:72-90. [PMID: 25448873] doi:10.1038/ajg.2014.385
24. Gohel TD, Burke CA, Lankaala P, Podugu A, Kiran RP, Thota PN, et al. Polypectomy rate: a surrogate for adenoma detection rate varies by colon segment, gender, and endoscopist. Clin Gastroenterol Hepatol. 2014;12:1137-42. [PMID: 24315881] doi:10.1016/j.cgh.2013.11.023
25. Williams JE, Holub JL, Faigel DO. Polypectomy rate is a valid quality measure for colonoscopy: results from a national endoscopy database. Gastrointest Endosc. 2012;75:576-82. [PMID: 22341104] doi:10.1016/j.gie.2011.12.012
26. Boroff ES, Gurudu SR, Hentz JG, Leighton JA, Ramirez FC. Polyp and adenoma detection rates in the proximal and distal colon. Am J Gastroenterol. 2013;108:993-9. [PMID: 23567353] doi:10.1038/ajg.2013.68
27. Patel NC, Islam RS, Wu Q, Gurudu SR, Ramirez FC, Crowell MD, et al. Measurement of polypectomy rate by using administrative claims data with validation against the adenoma detection rate. Gastrointest Endosc. 2013;77:390-4. [PMID: 23199647] doi:10.1016/j.gie.2012.09.032
28. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245-51. [PMID: 7722560]
29. Adams KF, Johnson EA, Chubak J, Kamineni A, Doubeni CA, Buist DS, et al. Development of an Algorithm to Classify Colonoscopy Indication from Coded Health Care Data. EGEMS (Wash DC). 2015;3:1171. [PMID: 26290883] doi:10.13063/2327-9214.1171
30. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509.
31. Kleinbaum D, Klein M. Survival Analysis: A Self-Learning Text. 3rd ed. New York: Springer; 2012.
32. Li R, Hertzmark E, Louie M, Chen L, Spiegelman D. The SAS LGTPHCURV9 macro. 3 July 2011. Accessed at https://cdn1.sph.harvard.edu/wp-content/uploads/sites/271/2012/09/lgtphcurv9-7-3-2011.pdf on 4 April 2017.
33. Ding P, VanderWeele TJ. Sensitivity Analysis Without Assumptions. Epidemiology. 2016;27:368-77. [PMID: 26841057] doi:10.1097/EDE.0000000000000457
34. So Y, Lin G, Johnston G. Using the PHREG Procedure to Analyze Competing-Risks Data. Cary, NC: SAS Institute, Inc; 2014.
35. Robertson DJ, Lieberman DA, Winawer SJ, Ahnen DJ, Baron JA, Schatzkin A, et al. Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. Gut. 2014;63:949-56. [PMID: 23793224] doi:10.1136/gutjnl-2012-303796
36. le Clercq CM, Bouwens MW, Rondagh EJ, Bakker CM, Keulen ET, de Ridder RJ, et al. Postcolonoscopy colorectal cancers are preventable: a population-based study. Gut. 2014;63:957-63. [PMID: 23744612] doi:10.1136/gutjnl-2013-304880
37. Farrar WD, Sawhney MS, Nelson DB, Lederle FA, Bond JH. Colorectal cancers found after a complete colonoscopy. Clin Gastroenterol Hepatol. 2006;4:1259-64. [PMID: 16996804]
38. Baxter NN, Warren JL, Barrett MJ, Stukel TA, Doria-Rose VP. Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty. J Clin Oncol. 2012;30:2664-9. [PMID: 22689809] doi:10.1200/JCO.2011.40.4772
39. Tehranifar P, Neugut AI, Phelan JC, Link BG, Liao Y, Desai M, et al. Medical advances and racial/ethnic disparities in cancer survival. Cancer Epidemiol Biomarkers Prev. 2009;18:2701-8. [PMID: 19789367] doi:10.1158/1055-9965. EPI-09-0305
40. Phelan JC, Link BG, Tehranifar P. Social conditions as fundamental causes of health inequalities: theory, evidence, and policy implications. J Health Soc Behav. 2010;51 Suppl:S28-40. [PMID: 20943581] doi:10.1177/0022146510383498
41. Ward E, Jemal A, Cokkinides V, Singh GK, Cardinez C, Ghafoor A, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54:78-93. [PMID: 15061598]
42. Mehta SJ, Jensen CD, Quinn VP, Schottinger JE, Zauber AG, Meester R, et al. Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System. J Gen Intern Med. 2016;31:1323-1330. [PMID: 27412426]
43. Bach PB, Pham HH, Schrag D, Tate RC, Hargraves JL. Primary care physicians who treat blacks and whites. N Engl J Med. 2004;351:575-84. [PMID: 15295050]
44. Butterly L, Robinson CM, Anderson JC, Weiss JE, Goodrich M, Onega TL, et al. Serrated and adenomatous polyp detection increases with longer withdrawal time: results from the New Hampshire Colonoscopy Registry. Am J Gastroenterol. 2014;109:417-26. [PMID: 24394752] doi:10.1038/ajg.2013.442
45. Brenner H, Chang-Claude J, Jansen L, Seiler CM, Hoffmeister M. Colorectal cancers occurring after colonoscopy with polyp detection: sites of polyps and sites of cancers. Int J Cancer. 2013;133:1672-9. [PMID: 23526227] doi:10.1002/ijc.28166
46. Dimou A, Syrigos KN, Saif MW. Disparities in colorectal cancer in African-Americans vs Whites: before and after diagnosis. World J Gastroenterol. 2009;15:3734-43. [PMID: 19673013]
47. Lieberman DA, Holub JL, Moravec MD, Eisen GM, Peters D, Morris CD. Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients. JAMA. 2008;300:1417-22. [PMID: 18812532] doi:10.1001/jama.300.12.1417
48. Corley DA, Jensen CD, Marks AR, Zhao WK, de Boer J, Levin TR, et al. Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs. Clin Gastroenterol Hepatol. 2013;11:172-80. [PMID: 22985608] doi:10.1016/j.cgh.2012.09.010
49. Jass JR. Serrated route to colorectal cancer: back street or super highway? [Editorial]. J Pathol. 2001;193:283-5. [PMID: 11241405]
50. Carethers JM, Murali B, Yang B, Doctolero RT, Tajima A, Basa R, et al. Influence of race on microsatellite instability and CD8+ T cell infiltration in colon cancer. PLoS One. 2014;9:e100461. [PMID: 24956473] doi:10.1371/journal.pone.0100461
51. Ashktorab H, Smoot DT, Carethers JM, Rahmanian M, Kittles R, Vosganian G, et al. High incidence of microsatellite instability in colorectal cancer from African Americans. Clin Cancer Res. 2003;9:1112-7. [PMID: 12631615]
52. Xicola RM, Gagnon M, Clark JR, Carroll T, Gao W, Fernandez C, et al. Excess of proximal microsatellite-stable colorectal cancer in African Americans from a multiethnic study. Clin Cancer Res. 2014;20:4962-70. [PMID: 25013126] doi:10.1158/1078-0432. CCR-14-0353
53. Lansdorp-Vogelaar I, Fedewa S, Lin CC, Virgo KS, Jemal A. Utilization of surveillance after polypectomy in the medicare population - a cohort study. PLoS One. 2014;9:e110937. [PMID: 25393312] doi:10.1371/journal.pone.0110937
54. Cooper GS, Kou TD, Barnholtz Sloan JS, Koroukian SM, Schluchter MD. Use of colonoscopy for polyp surveillance in Medicare beneficiaries. Cancer. 2013;119:1800-7. [PMID: 23436321] doi:10.1002/cncr.27990
55. Torre LA, Sauer AM, Chen MS Jr, Kagawa-Singer M, Jemal A, Siegel RL. Cancer statistics for Asian Americans, Native Hawaiians, and Pacific Islanders, 2016: Converging incidence in males and females. CA Cancer J Clin. 2016;66:182-202. [PMID: 26766789] doi: 10.3322/caac.21335
56. Sung JJ, Lau JY, Young GP, Sano Y, Chiu HM, Byeon JS, et al; Asia Pacific Working Group on Colorectal Cancer. Asia Pacific consensus recommendations for colorectal cancer screening. Gut. 2008;57:1166-76. [PMID: 18628378] doi:10.1136/gut.2007.146316
57. Schenck AP, Klabunde CN, Warren JL, Peacock S, Davis WW, Hawley ST, et al. Data sources for measuring colorectal endoscopy use among Medicare enrollees. Cancer Epidemiol Biomarkers Prev. 2007;16:2118-27. [PMID: 17932360]
58. Ko CW, Dominitz JA, Green P, Kreuter W, Baldwin LM. Accuracy of Medicare claims for identifying findings and procedures performed during colonoscopy. Gastrointest Endosc. 2011;73:447-453.e1. [PMID: 20950800] doi:10.1016/j.gie.2010.07.044
59. Francis DL, Rodriguez-Correa DT, Buchner A, Harewood GC, Wallace M. Application of a conversion factor to estimate the adenoma detection rate from the polyp detection rate. Gastrointest Endosc. 2011;73:493-7. [PMID: 21353846] doi:10.1016/j.gie.2011.01.005
60. Chen SC, Rex DK. Variable detection of nonadenomatous polyps by individual endoscopists at colonoscopy and correlation with adenoma detection. J Clin Gastroenterol. 2008;42:704-7. [PMID: 18496392] doi:10.1097/MCG.0b013e31817236e5
61. Do A, Weinberg J, Kakkar A, Jacobson BC. Reliability of adenoma detection rate is based on procedural volume. Gastrointest Endosc. 2013;77:376-80. [PMID: 23211748] doi:10.1016/j.gie.2012.10.023
62. Baldwin LM, Adamache W, Klabunde CN, Kenward K, Dahlman C, L Warren J. Linking physician characteristics and medicare claims data: issues in data availability, quality, and measurement. Med Care. 2002;40:IV-82-95. [PMID: 12187173]
63. Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. JAMA. 1998;280:1747-51. [PMID: 9842949]
64. Rogart JN, Siddiqui UD, Jamidar PA, Aslanian HR. Fellow involvement may increase adenoma detection rates during colonoscopy. Am J Gastroenterol. 2008;103:2841-6. [PMID: 18759826] doi: 10.1111/j.1572-0241.2008.02085.x
65. Diez-Roux AV, Kiefe CI, Jacobs DR Jr, Haan M, Jackson SA, Nieto FJ, et al. Area characteristics and individual-level socioeconomic position indicators in three population-based epidemiologic studies. Ann Epidemiol. 2001;11:395-405. [PMID: 11454499]
66. Berkowitz SA, Traore CY, Singer DE, Atlas SJ. Evaluating areabased socioeconomic status indicators for monitoring disparities within health care systems: results from a primary care network. Health Serv Res. 2015;50:398-417. [PMID: 25219917] doi:10.1111/1475-6773.12229
67. Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, Woodward M. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer. 2009;125:171-80. [PMID: 19350627] doi: 10.1002/ijc.24343